Full-term ectogenesis
Gestating a mammal from fertilized egg to birth entirely in machinery, with no uterus at any stage.
State of the art
Ex utero mouse culture reaches roughly mid-gestation (2026); artificial placenta work starts at human 23-25-week equivalence; no organism of any species has been gestated start to finish outside a body.
- The gap between day-14 embryo culture and artificial-placenta viability covers organogenesis, the hardest and least substitutable phase
- No artificial implantation or placental organ exists to supply hormones and nutrient exchange during that gap
- Scaling implies thousands of parallel units with sterility and uninterrupted power for nine months each
Who’s working on it
- Jacob HannaResearcherWeizmann Institute of Science
Grew natural mouse embryos ex utero from E5.5 to E11 through organogenesis (Nature, 2021) and generated transgene-free post-gastrulation whole embryo models from naive stem cells (Cell Stem Cell, 2025); holds an ERC grant titled ExUteroEmbryogenesis
- Alejandro Aguilera-CastrejonResearcherJanelia Research Campus, HHMI
Built the roller and perfusion ex utero culture platform in the Hanna lab and now works explicitly toward birthing a mouse from an incubator
- Renewal BioStartup
Israeli company co-founded by Hanna in 2022 that licensed the Weizmann ex utero and synthetic-embryo patents (about $9M raised via NFX) to grow early tissue as a cell source
- Vitara Biomedical ↗Startup
Working the opposite end of the same problem - fluid-filled support from roughly 22 weeks of human gestation onward, the only part of full-term ectogenesis anywhere near clinical use
- Nicolas RivronResearcherInstitute of Molecular Biotechnology (IMBA), Vienna
Pioneered human blastoids and implantation models, the stem-cell side of reconstructing the earliest gestation stages outside a body
- Perinatal Life Support (PLS) consortiumProgram
EU Horizon 2020 consortium (grant 863087) developing a liquid-based perinatal life support system and the clinical procedures to transfer an infant into it
What to invest in
| Kind | Investment | Scale |
|---|---|---|
| research | Primate ex utero gestation program extending culture stepwise past the organogenesis gap | $$$ $100M – $1B |
| engineering | Integrated gestation unit combining engineered placental exchange, hormone control and sterile fluid management | $$$ $100M – $1B |
Depends on
Required by
No other capability builds on this directly.